<DOC>
	<DOC>NCT00099801</DOC>
	<brief_summary>The safety and efficacy of FTY720 is being evaluated in patients who receive a kidney transplant.</brief_summary>
	<brief_title>Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Patients undergoing their first kidney transplant Male or female age 18 to 65 years Patients in need of second kidney transplant or multiorgan transplants.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Kidney, Transplantation, Rejection, Immunosuppression</keyword>
</DOC>